Nautilus Biotechnology (NAUT)'s 30-day implied volatility (IV30) was 143.5% at the close on October 27, 2026, up from 139.8% the day before, against a 52-week range of 60.1% to 189.2%. Its 20-day historical volatility was 206.4%.
Data as of October 27, 2026.